Supplementary Table S6.1.

Metadata, genome assembly statistics and antibiotic resistance phenotype and genotype data of the novel sequenced Portuguese Neisseria gonorrhoeae isolates enrolled in the present study. NA - Not applicable; ND - Not determined; P/A - Presence/Absence; MSM – Men who have sex with men; MSMW – Men who have sex with men and women; AZM – Azithromycin; CIP – Ciprofloxacin; CFM – Cefixime; CRO – Ceftriaxone; PEN – Penicillin; RI – Rifampin; SPT – Spectinomycin; TET – Tetracycline; CEF – cephalosporins; GEN – Gentamicin; β-LACT – β-lactamase; SUL – Sulfonamides; rXXX – Resistant to; dXXX – Decreased susceptibility to; AMR – antimicrobial resistance; MLST – Multi-locus Sequence Type; NG-MAST – Neisseria gonorrhoeae Multi-Antigen Sequence Type; cgMLST – core-genome Multi-locus Sequence Typing; ENA – European Nucleotide Archive; NUT – Nomenclature of Territorial Units for Statistics; MIC - Minimum inhibitory concentration; RP - Resistance phenotype. *For this study, if the patient’s region of residence was not available, the geographic region of the reporting laboratory was attributed to the isolate. **Due to the lack of an established breakpoint, gentamicin susceptibility was classified for analysis purposes based on interpretive results from previous studies: as susceptible when MIC ≤ 4, and resistant when MIC > 16 mg/L, according to Boiko et al., 2019; APMIS, 127(7):503-509 (doi:10.1111/apm.12948) and Brown et al., 2010; Sex Transm Dis., 37(3):169-172 (doi:10.1097/OLQ.0b013e3181bf575c).